human AFP protein

RefSeq NM_001134

Also Known As:

AFP protein, human; AF glycoprotein, human; AFP-L3 protein, human; alpha-fetoprotein, human; alpha-fetospecific glycoprotein, human; alpha-glycoprotein, fetospecific, human; glycosylated AFP protein, human

Networked: 48 relevant articles (1 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Stenman, Ulf-Håkan: 2 articles (12/2008 - 01/2008)
2.	Damjanov, Ivan: 1 article (04/2021)
3.	Amler, Evzen: 1 article (11/2017)
4.	Boccellino, Mariarosaria: 1 article (11/2017)
5.	Botti, Gerardo: 1 article (11/2017)
6.	Buonerba, Carlo: 1 article (11/2017)
7.	Caraglia, Michele: 1 article (11/2017)
8.	Cavaliere, Carla: 1 article (11/2017)
9.	Chieffi, Paolo: 1 article (11/2017)
10.	D'Aniello, Carmine: 1 article (11/2017)

Related Diseases

1.	Neoplasms (Cancer) 11/20/2010 - "Histology, primary tumor location, response, and progression-free interval after first-line treatment, as well as levels of alpha fetoprotein, human chorionic gonadotrophin, and the presence of liver, bone, or brain metastases at salvage were identified as independent prognostic variables and used to build a prognostic model in the training set. " 04/01/2015 - "Serum alpha-fetoprotein, human chorionic gonadotropin and CA 125 levels as well as follow-up data were recorded from patient charts and tumor histology was re-evaluated. " 01/01/2008 - "Serum levels of alpha-fetoprotein, human chorionic gonadotropin and CA 125 were determined, and immunohistochemistry for CA 125 as well as the pluripotent stem cell markers AP-2gamma and Oct-3/4 was performed in tumor specimens and the NCC-IT human germinoma cell line. " 07/01/1978 - "The potential effect of these techniques upon the diagnosis and classification of neoplasia is illustrated by the application of immunoperoxidase methods to the study of alpha-fetoprotein, human chorionic gonadotrophin, and steroid hormone localization in tumors of the ovary and testis." 05/01/1986 - "alpha-Fetoprotein, human chorionic gonadotropin, and carcinoembryonic antigen were found in the tumor tissue, using the immunoperoxidase method. "
2.	Brain Neoplasms (Brain Tumor) 11/20/2010 - "Histology, primary tumor location, response, and progression-free interval after first-line treatment, as well as levels of alpha fetoprotein, human chorionic gonadotrophin, and the presence of liver, bone, or brain metastases at salvage were identified as independent prognostic variables and used to build a prognostic model in the training set. "
3.	Down Syndrome (Down's Syndrome) 06/01/2001 - "Women of both groups had a second trimester serum screening for Down's Syndrome using alpha fetoprotein, human chorionic gonadotrophin (hCG) and unconjugated oestriol (uE3); and they also underwent genetic amniocentesis. " 12/01/1994 - "The role of maternal serum alpha-fetoprotein, human chorionic gonadotrophin and oestriol in the antenatal screening of Down's syndrome." 07/01/1999 - "To study the detection rates of second trimester ultrasound screening for neural tube defects (NTD), abdominal wall defects (AWD) and Down's syndrome (DS) in low risk populations at tertiary centers, and to compare the ultrasound screening detection rates with those that were obtainable by biochemical serum screening (double test: alpha-fetoprotein/human chorion gonadotrophin/age test). " 10/01/1994 - "Second-trimester diurnal variation of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol: is it present and does it affect the prediction of a patient's risk for fetal Down syndrome?" 09/01/1993 - "A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol."
4.	Neural Tube Defects (Exencephaly) 07/01/1999 - "To study the detection rates of second trimester ultrasound screening for neural tube defects (NTD), abdominal wall defects (AWD) and Down's syndrome (DS) in low risk populations at tertiary centers, and to compare the ultrasound screening detection rates with those that were obtainable by biochemical serum screening (double test: alpha-fetoprotein/human chorion gonadotrophin/age test). " 06/01/1994 - "Between September 1st 1990 and Juli 31st 1993, 5071 pregnant women were screened prospectively by the "triple-test", including maternal serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated oestriol in order to detect chromosomal anomalies and open neural tube defects. " 02/01/2006 - "There are also occasional reports of prenatal diagnosis of IAD by findings on the maternal triple-marker screen (TMST), a combined serum analyte test that measures levels of alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol for the detection of Down syndrome and open neural-tube defects. " 04/01/2006 - "Triple test with measured maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol combination as a routine procedure for fetal Down's syndrome, trisomy 18 and neural tube defect screening has some intrinsic problems, such as precision. " 10/01/1994 - "Maternal serum screening (MSS) measures three serum markers: alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol, from which the risk of fetal Down syndrome or open neural tube defect is calculated. "
5.	Aneuploidy (Aneuploid) 10/01/2003 - "The study was undertaken to determine the screen-positive rates of multiple-marker screening tests in pregnant women who are positive for human immunodeficiency virus (HIV) at our institution for open neural tube defects and aneuploidy, for both triple (alpha-fetoprotein, human chorionic gonadotropin [hCG], unconjugated estriol) and quad (alpha-fetoprotein, hCG, unconjugated estriol, inhibin A) screens, and to compare these rates with a matched control group. "

Related Drugs and Biologics

1.	Chorionic Gonadotropin (Human Chorionic Gonadotropin)
2.	Estriol (Epiestriol)
3.	alpha-Fetoproteins (alpha-Fetoprotein)
4.	Tumor Biomarkers (Tumor Markers)
5.	prostatic acid phosphatase
6.	Steroids
7.	Hormones (Hormone)
8.	inhibin A
9.	L-Lactate Dehydrogenase (Lactate Dehydrogenase)
10.	Carcinoembryonic Antigen

Related Therapies and Procedures

1.	Therapeutics
2.	Drug Therapy (Chemotherapy)